Progression of index metastases in oligometastatic hormone-sensitive prostate cancer: implications for metastases directed therapy?
Parth Verma(Homi Bhabha National Institute), Vedang Murthy(Homi Bhabha National Institute), Priyamvada Maitre(Homi Bhabha National Institute), Sayak Choudhury(Society of Nuclear Medicine and Molecular Imaging), Suchismita Ghosh(Homi Bhabha National Institute), Archi Agrawal(Tata Memorial Hospital), Nishika Murarka(Homi Bhabha National Institute), Getha Krishnasamy(Homi Bhabha National Institute)
Cited by 3
Related Papers
The Lancet Commission on prostate cancer: planning for the surge in cases
|The Lancet|2024|694
Management of Patients with Advanced Prostate Cancer: The Report of the Advanced Prostate Cancer Consensus Conference APCCC 2017
|European Urology|2017|644
Management of Patients with Advanced Prostate Cancer: Report of the Advanced Prostate Cancer Consensus Conference 2019
|European Urology|2020|396
Diagnostic performance of post-treatment FDG PET or FDG PET/CT imaging in head and neck cancer: a systematic review and meta-analysis
|European Journal of Nuclear Medicine and Molecular Imaging|2011|377
Once-a-Week Versus Once-Every-3-Weeks Cisplatin Chemoradiation for Locally Advanced Head and Neck Cancer: A Phase III Randomized Noninferiority Trial
|Journal of Clinical Oncology|2017|340